Ciprofloxacin may be a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. It’s a second-generation fluoroquinolone antibacterial. It kills bacteria by interfering with the enzymes that cause DNA to rewind after being copied, which stops synthesis of DNA and of protein. Ciprofloxacin isn't to be utilized in infants as they have not developed sufficient enzymes to metabolize the drug. Severe adverse reaction will occur during this patient group.
Ciprofloxacin is used to treat variety of infections including: infections of bones and joints, endocarditic, gastroenteritis, malignant otitis external, respiratory tract infections, cellulites, tract infections, prostitutes, anthrax, and cancroid, among others. This medication is used to treat a variety of bacterial infections. Ciprofloxacin belongs to a category of medicine called quinolone antibiotics. It works by stopping the expansion of bacteria. This antibiotic treats only bacterial infections. It’ll not work for virus infections (such as common cold, flu). Using any antibiotic when it's not needed can cause it to not work for future infections.
The global API market is poised to grow at a CAGR of around 6.6 per cent over the next decade to reach approximately US $238.8 billion by 2025. The prominent trends that the market is witnessing include, growing geriatric population, rapid growth in biopharmaceuticals sector and technological advancements in API manufacturing.
Indian pharmaceutical sector is expected to grow to US$ 100 billion, while medical device market is expected to grow US$ 25 billion by 2025. Pharmaceuticals export from India stood at US$ 20.70 billion in FY20. Pharmaceutical export include bulk drugs, intermediates, drug formulations, biological, Ayush and herbal products and surgical. India's biotechnology industry comprising biopharmaceuticals, bio-services, bio-agriculture, bio-industry, and bioinformatics is expected grow at an average growth rate of around 30 per cent a y-o-y to reach US$ 100 billion by 2025. Thus, due to demand it is best to invest in this project.
Few Indian major players are as under
Aarti Drugs Ltd.
Aurobindo Pharma Ltd.
Cipla Ltd.
Indoco Remedies Ltd
Kores (India) Ltd.
Wockhardt Ltd.
Sun Pharma Medisales Pvt. Ltd.